{"id":"doi:10.1016/s0140-6736(15)61252-1","kind":"article","title":"Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study","authors":["Sotirios Tsimikas","Nicholas J. Viney","Steven G. Hughes","Walter Singleton","Mark J. Graham","Brenda F. Baker","Jennifer Burkey","Qingqing Yang","Santica M. Marcovina","Richard S. Geary","Rosanne M. Crooke","Joseph Lee Witztum"],"author_count":12,"year":2015,"published":"2015-07-22","venue":"The Lancet","cited_by":460,"doi":"10.1016/s0140-6736(15)61252-1","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/s0140-6736(15)61252-1","archive_url":"https://space-kitty.com/papers/doi:10.1016/s0140-6736(15)61252-1","updated":null,"pmid":"26210642","pmcid":null,"openalex_id":"W1708837772","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"peer_reviewed":null,"categories":["Lipoproteins and Cardiovascular Health"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}